Skip to the content
Search
Beyond Type 1
Menu
BEYOND TYPE 1
Show sub menu
About
Board of Directors
The Team
Leadership Council
Portfolio
Press
Careers
Contact
Join Us
Diabetes
Type 1 Info
Type 2 Info
Diabetes Management
Newly Diagnosed
Forms Of Diabetes
Autoimmune Diseases
Pregnancy with Type 1 Diabetes
Research
Resources
Stories
Diabetes News
Diabetes Management
Diabetes + Exercise
Mental Health + Diabetes
Food and Diabetes
School Resources
Sex, Drugs + Rock & Roll
Travel + Adventure
Previously Healthy
GetInsulin.org
Newsletter
Programs
Beyond Type 1 App
Beyond Scholars
GetInsulin.org
Community Table
Marathon Team
Snail Mail Club
TuDiabetes
Type 1 Signs
Jesse Was Here
Advocacy
Donate
Search
Tag:
Advocacy
Diabetes Community Survey Shows Drug Costs Still Ranks Highest Access Concern
A majority of respondents (56%) ranked access to affordable insulin and diabetes drugs as their most important access issue.
Over Insulin Pricing, Mississippi AG Sues Insulin Manufacturers and Pharmacy Benefit Managers
MS attorney general Lynn Fitch filed a lawsuit against PBMs & insulin manufacturers for allegedly working together to inflate insulin prices.
Diabetes Difference Makers Spotlight: Diabetes Will’s Way
Lisa Oberndorfer was a recipient of a grant through Diabetes Difference Makers. Diabetes Difference Makers is made possible in partnership with Abbott, makers of the FreeStyle Libre 2.
Combating Bullying: How One Person With Diabetes Fought To Test Her Blood Sugar In The Workplace
Sheri Byrne shares her experience on how she fought workplace bullying due to diabetes and advocated for herself.
Asian Isn’t A Monolith: Why More Specific Data Matters in Diabetes Research
Data on how diabetes impacts specific ethnic groups could help us better support people within Asian American Pacific Islander communities.
Why are Black and Hispanic Youth with T1D Using Less Diabetes Technology?
We interviewed Dr. Shivani Agarwal about the racial-ethnic and socio-economic disparities in type 1 diabetes care. Here's what we learned.
Inside the Senate Report on Rising Insulin Prices
A January 2021 Senate Finance Committee report dug into the rapidly increasing cost of insulin. Here, we summarize and explain their findings.
How Rebates—Most of the Cost of Your Insulin—Work
The rebate system creates up to 70% of the current list price of insulin in the US, and it doesn’t have to be this way.
Get the Facts on Insulin Pricing + The Presidential Transition
A flurry of misinformation is stoking fears that the Biden Admin paused or reversed a previous Trump Admin policy that lowered the price of insulin.
New Year, New Administration: What’s Coming For US Healthcare Policy
With a new governmental administration, it is likely we will see notable and impactful movement in healthcare policy. What can we expect?
Congress Renews Funding for Special Diabetes Program
On Dec 22, 2020, Congress renewed the Special Diabetes Program, providing $150 million annually in type 1 diabetes research funding until 2023
From Diagnosis Through Complications: Disparities in Diabetes Care
Recent research is confirming what many have experienced - that beginning at diagnosis, ethnic minorities in the US face more challenges navigating diabetes and care than their white counterparts.
Racial + Ethnic Disparities in Diabetes Care
Five panelists discuss the racial and ethnic disparities in diabetes care as part of September Summits.
All About State-Based Insulin Price Cap Laws
While we advocate for federal actions on insulin pricing, state based insulin price cap laws are leading the charge.
The Power of the Diabetes Vote
Over 34 million Americans and their families are impacted by diabetes. Those more than 34 million votes add up, and every individual vote is important. Click above to find out how your vote can make ...
Posts navigation
←
Newer
Posts
1
2
3
4
…
15
Older
Posts
→